{"id":197947,"date":"2026-08-12T10:54:18","date_gmt":"2026-08-12T05:24:18","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=197947"},"modified":"2026-08-12T10:54:19","modified_gmt":"2026-08-12T05:24:19","slug":"nephrocare-healthcare-q1-results-fy27-pat-35-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/","title":{"rendered":"Nephrocare Healthcare Q1 FY27 Results: Revenue Rs 281 Cr, PAT Rs 35 Cr and Key Highlights"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Nephrocare Healthcare Q1 FY27: Revenue Rs 281 Cr (vs nil prior year). PAT Rs 35 Cr. Results August 11, 2026. CMP Rs 717.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/nephroplus\/nephrocare-health-serv-l-share-price-today\">Nephrocare Healthcare<\/a> Q1 FY27 results were announced on August 11, 2026, reporting a net profit (PAT) of Rs 35 crore, against negligible profits in the year-ago quarter. Revenue from operations rose to Rs 281 crore, against a negligible base in the year-ago quarter. The Nephrocare Healthcare Q1 FY27 results are on a consolidated basis for the quarter ended June 30, 2026.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=nephrocare-healthcare-q1-results-fy27-pat-35-\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Nephrocare_Healthcare_Q1_FY27_Financial_Highlights\" title=\"Nephrocare Healthcare Q1 FY27 Financial Highlights\">Nephrocare Healthcare Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Nephrocare_Healthcare_Q1_FY27_Performance_Analysis\" title=\"Nephrocare Healthcare Q1 FY27 Performance Analysis\">Nephrocare Healthcare Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Key_Business_Factors_in_Nephrocare_Healthcare_Q1_FY27\" title=\"Key Business Factors in Nephrocare Healthcare Q1 FY27\">Key Business Factors in Nephrocare Healthcare Q1 FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#1_Revenue_Growth_Expanded_the_Top_Line\" title=\"1. Revenue Growth Expanded the Top Line\">1. Revenue Growth Expanded the Top Line<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#2_Gross_Profit_Reflected_Operational_Gains\" title=\"2. Gross Profit Reflected Operational Gains\">2. Gross Profit Reflected Operational Gains<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#3_Net_Profit_Growth_Signals_Improving_Profitability\" title=\"3. Net Profit Growth Signals Improving Profitability\">3. Net Profit Growth Signals Improving Profitability<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Nephrocare_Healthcare_FY27_Outlook_After_Q1_Results\" title=\"Nephrocare Healthcare FY27 Outlook After Q1 Results\">Nephrocare Healthcare FY27 Outlook After Q1 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Nephrocare_Healthcare_Stock_Performance\" title=\"Nephrocare Healthcare Stock Performance\">Nephrocare Healthcare Stock Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Key_Risks_to_Watch_After_Nephrocare_Healthcare_Q1_FY27_Results\" title=\"Key Risks to Watch After Nephrocare Healthcare Q1 FY27 Results\">Key Risks to Watch After Nephrocare Healthcare Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#1_Sector-Specific_Demand_Headwinds\" title=\"1. Sector-Specific Demand Headwinds\">1. Sector-Specific Demand Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#2_Input_Cost_and_Margin_Pressure\" title=\"2. Input Cost and Margin Pressure\">2. Input Cost and Margin Pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#3_Macroeconomic_and_Regulatory_Uncertainty\" title=\"3. Macroeconomic and Regulatory Uncertainty\">3. Macroeconomic and Regulatory Uncertainty<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Frequently_Asked_Questions_on_Nephrocare_Healthcare_Q1_FY27_Results\" title=\"Frequently Asked Questions on Nephrocare Healthcare Q1 FY27 Results\">Frequently Asked Questions on Nephrocare Healthcare Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#When_were_the_Nephrocare_Healthcare_Q1_FY27_results_announced\" title=\"When were the Nephrocare Healthcare Q1 FY27 results announced?\">When were the Nephrocare Healthcare Q1 FY27 results announced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#What_is_the_PAT_in_the_Nephrocare_Healthcare_Q1_FY27_results\" title=\"What is the PAT in the Nephrocare Healthcare Q1 FY27 results?\">What is the PAT in the Nephrocare Healthcare Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#What_was_the_revenue_in_the_Nephrocare_Healthcare_Q1_FY27_results\" title=\"What was the revenue in the Nephrocare Healthcare Q1 FY27 results?\">What was the revenue in the Nephrocare Healthcare Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Did_Nephrocare_Healthcare_announce_any_dividend_with_the_Q1_FY27_results\" title=\"Did Nephrocare Healthcare announce any dividend with the Q1 FY27 results?\">Did Nephrocare Healthcare announce any dividend with the Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#What_is_the_Nephrocare_Healthcare_FY27_outlook_after_Q1_results\" title=\"What is the Nephrocare Healthcare FY27 outlook after Q1 results?\">What is the Nephrocare Healthcare FY27 outlook after Q1 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/nephrocare-healthcare-q1-results-fy27-pat-35-crore\/#Is_Nephrocare_Healthcare_a_good_buy_after_Q1_FY27_results\" title=\"Is Nephrocare Healthcare a good buy after Q1 FY27 results?\">Is Nephrocare Healthcare a good buy after Q1 FY27 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Nephrocare_Healthcare_Q1_FY27_Financial_Highlights\"><\/span><strong>Nephrocare Healthcare Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below summarises the key financial metrics from the Nephrocare Healthcare Q1 FY27 results compared with the same quarter of the previous year (Q1 FY26).<\/p>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Q1 FY27 (Jun 2026)<\/th>\n<th>Q1 FY26 (Jun 2025)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Revenue from Operations (Rs Cr)<\/td>\n<td>Rs 281 Cr<\/td>\n<td>Nil<\/td>\n<td>NA<\/td>\n<\/tr>\n<tr>\n<td>Gross Profit (Rs Cr)<\/td>\n<td>Rs 39 Cr<\/td>\n<td>Nil<\/td>\n<td>NA<\/td>\n<\/tr>\n<tr>\n<td>Net Profit \/ (Loss) &#8211; PAT (Rs Cr)<\/td>\n<td>Rs 35 Cr<\/td>\n<td>Nil<\/td>\n<td>NA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction stock opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on current market momentum, sector trends and growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/log-in?redirectUrl=%2Fuser%2Fpayment%3FplanType%3DALL_PRO%2BPLANS%26cacheClear%3D1780639629052\">Top Stock Picks<\/a> on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=nephrocare-healthcare-q1-fy27\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Nephrocare_Healthcare_Q1_FY27_Performance_Analysis\"><\/span><strong>Nephrocare Healthcare Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Use the Univest Screener to Track Live Fundamentals of Indian Stocks<\/strong><\/a><\/p>\n<p>Nephrocare healthcare q1 fy27 results show The june 2026 quarter&#8217;s revenue at Rs 281 crore against a negligible prior-year base. Gross profit improved to Rs 39 crore in the June 2026 quarter.<\/p>\n<p>Net profit in the June 2026 quarter stood at Rs 35 crore, against negligible profits in the year-ago quarter. Investors tracking Nephrocare Healthcare quarterly results should verify these figures against the official BSE and NSE filings.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Nephrocare_Healthcare_Q1_FY27\"><\/span><strong>Key Business Factors in Nephrocare Healthcare Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Revenue_Growth_Expanded_the_Top_Line\"><\/span><strong>1. Revenue Growth Expanded the Top Line<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue stood at rs 281 crore with no meaningful prior-year comparison base. Demand conditions in the Healthcare and Dialysis segment supported the volume and realisation improvement seen in the June 2026 quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Gross_Profit_Reflected_Operational_Gains\"><\/span><strong>2. Gross Profit Reflected Operational Gains<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Gross profit stood at Rs 39 crore for the June 2026 quarter. Operating leverage in the Healthcare and Dialysis business supported margin outcomes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Net_Profit_Growth_Signals_Improving_Profitability\"><\/span><strong>3. Net Profit Growth Signals Improving Profitability<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>PAT rose to Rs 35 crore, against negligible profits in the year-ago quarter. The profitability improvement reflects the company&#8217;s ability to convert revenue growth into bottom-line gains within the Healthcare and Dialysis space.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No dividend has been declared alongside the Nephrocare Healthcare quarterly results for the quarter ended June 2026. Investors may track future announcements via BSE India and NSE India portals.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Nephrocare_Healthcare_FY27_Outlook_After_Q1_Results\"><\/span><strong>Nephrocare Healthcare FY27 Outlook After Q1 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nephrocare Healthcare Q1 FY27 results set a broadly positive tone for the full financial year. Revenue of Rs 281 crore and a net profit (PAT) of Rs 35 crore provide a foundation for further improvement. Investors monitoring Nephrocare Healthcare Q1 results should track demand conditions in Healthcare and Dialysis, input cost trajectories, and any capacity or business expansion announcements that could shape earnings through the remainder of FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Nephrocare_Healthcare_Stock_Performance\"><\/span><strong>Nephrocare Healthcare Stock Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Nephrocare Healthcare live share price and upcoming quarterly results.<\/em><\/p>\n<p>Nephrocare Healthcare share price stood at Rs 717 on August 11, 2026, the day the quarterly results were declared. Post-results, the market will assess whether the Healthcare and Dialysis company&#8217;s financial performance justifies the current valuation. Investors should verify the latest price and fundamentals on BSE and NSE before making any investment decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Nephrocare_Healthcare_Q1_FY27_Results\"><\/span><strong>Key Risks to Watch After Nephrocare Healthcare Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Sector-Specific_Demand_Headwinds\"><\/span><strong>1. Sector-Specific Demand Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A slowdown in the Healthcare and Dialysis sector could weigh on Nephrocare Healthcare revenue and profitability beyond what the June 2026 quarter already reflects.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Input_Cost_and_Margin_Pressure\"><\/span><strong>2. Input Cost and Margin Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Rising raw material or operational costs could compress gross margins and limit net profit recovery in subsequent quarters of FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Macroeconomic_and_Regulatory_Uncertainty\"><\/span><strong>3. Macroeconomic and Regulatory Uncertainty<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Inflation, interest rate movements, and regulatory changes remain key risks to the earnings trajectory of Nephrocare Healthcare through FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nephrocare Healthcare Q1 FY27 results report revenue of Rs 281 crore and a net profit (PAT) of Rs 35 crore, against negligible profits in the year-ago quarter. The June 2026 quarterly performance reflects the company&#8217;s position in the Healthcare and Dialysis space. Investors should study the full financials on BSE and NSE and consult a SEBI-registered advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Nephrocare_Healthcare_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Nephrocare Healthcare Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_were_the_Nephrocare_Healthcare_Q1_FY27_results_announced\"><\/span><strong>When were the Nephrocare Healthcare Q1 FY27 results announced?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The June 2026 quarterly results for Nephrocare Healthcare were announced on August 11, 2026, covering the quarter ended June 30, 2026. The consolidated results were filed with BSE and NSE on the same date.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PAT_in_the_Nephrocare_Healthcare_Q1_FY27_results\"><\/span><strong>What is the PAT in the Nephrocare Healthcare Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> PAT (net profit) stood at Rs 35 crore in the June 2026 quarter, against negligible profits in the year-ago quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_revenue_in_the_Nephrocare_Healthcare_Q1_FY27_results\"><\/span><strong>What was the revenue in the Nephrocare Healthcare Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue for the June 2026 quarter stood at Rs 281 crore against a negligible prior-year base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Nephrocare_Healthcare_announce_any_dividend_with_the_Q1_FY27_results\"><\/span><strong>Did Nephrocare Healthcare announce any dividend with the Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No dividend has been declared alongside the June 2026 quarterly results. Investors may track future Nephrocare Healthcare dividend announcements through the BSE and NSE portals.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Nephrocare_Healthcare_FY27_outlook_after_Q1_results\"><\/span><strong>What is the Nephrocare Healthcare FY27 outlook after Q1 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The June 2026 quarterly performance signals a positive start to FY27 for Nephrocare Healthcare. Key factors to watch include revenue trends, margin performance, and Healthcare and Dialysis sector demand through the rest of the financial year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Nephrocare_Healthcare_a_good_buy_after_Q1_FY27_results\"><\/span><strong>Is Nephrocare Healthcare a good buy after Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Q1 FY27 financial performance of Nephrocare Healthcare reflects improving trends in the June 2026 quarter. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nephrocare Healthcare Q1 FY27 results: Revenue Rs 281 Cr, PAT Rs 35 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.<\/p>\n","protected":false},"author":35,"featured_media":197946,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-197947","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["197946"],"_edit_lock":["1786512262:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["71"],"rank_math_title":["Nephrocare Healthcare Q1 FY27 Results: Revenue and PAT Highlights"],"rank_math_description":["Nephrocare Healthcare Q1 FY27 results: Revenue Rs 281 Cr, PAT Rs 35 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here."],"rank_math_focus_keyword":["Nephrocare Healthcare Q1 FY27 results"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["36178"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/nephrocare-healthcare-q1-results-fy27-pat-35-crore.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/197947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=197947"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/197947\/revisions"}],"predecessor-version":[{"id":198342,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/197947\/revisions\/198342"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/197946"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=197947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=197947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=197947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}